PRKDC and cancer: In the following paragraphs, we will detail the activation pathway, and compare the unique features of mouse models with null or KD mutations of ATM, ATR and DNA-PKcs (Table 1) and attempt to summarize their common features and their implications in human disease and cancer therapy.